Pissarra Susana, Rocha Gustavo, Acevedo Inês, Guimarães Hercília
Departamento de Pediatria, HS João, Porto.
Acta Med Port. 2005 Mar-Apr;18(2):163-8. Epub 2005 Apr 28.
Pulmonary Alveolar Proteinosis (PAP) is a rare entity characterized by the intra-alveolar accumulation of proteinaceous PAS positive and diastase resistant material. Its pathogenesis remains unclear, although a surfactant protein B deficiency and changes in the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor have been proposed as involved mechanisms. Clinically two forms of PAP occur in the pediatric age group: acquired and congenital. The congenital form, very rare, presents in the neonatal period with respiratory insufficiency that starts in the first hours of life and is rapidly progressive, despite therapeutic measures. A definitive diagnosis is based on characteristic histological and immunohistochemical findings of pulmonary samples obtained by lung biopsy. The authors report on a case of Congenital Pulmonary Alveolar Proteinosis that is not associated with SP-B deficiency.
肺泡蛋白沉积症(PAP)是一种罕见的疾病,其特征为肺泡内积聚PAS阳性且耐淀粉酶的蛋白质物质。尽管有人提出表面活性蛋白B缺乏和粒细胞-巨噬细胞集落刺激因子(GM-CSF)受体变化是其发病机制,但该病的发病机制仍不清楚。临床上,PAP在儿童年龄组中有两种形式:获得性和先天性。先天性形式非常罕见,在新生儿期出现呼吸功能不全,出生后数小时开始,尽管采取了治疗措施仍迅速进展。明确诊断基于通过肺活检获得的肺组织样本的特征性组织学和免疫组化结果。作者报告了一例与表面活性蛋白B缺乏无关的先天性肺泡蛋白沉积症病例。